Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
Britain is set for the hottest day of the year today, with temperatures forecast to hit up to 34C (93F).
The Airports Commission is to publish its report and recommendations on whether an extra runway should be built at Gatwick or Heathrow.
Searing heat surges it's way in, then pouring down as we start July.